South Korean Scientists Successfully Develop a New Technique to Diagnose 12 Types of Cancer Using a Common Mutated Protein
Professor Lee from the Korean Institute of Science and Technology, along with three colleagues from YunSe University, has discovered that all 12 types of cancer share a common mutated protein known as “NeoNoVo.” They utilized this principle to create a new test for cancer diagnosis. The mere detection of the mutated protein “NeoNoVo” can confirm the presence of cancer.
South Korea – Invention of a Test to Diagnose 12 Types of Cancer.
Image: Laryngeal Cancer. (Illustrative Image)
Clinical trials conducted by the scientists show that this new test can diagnose up to 12 types of cancer, including stomach cancer, liver cancer, breast cancer, pancreatic cancer, kidney cancer, and colorectal cancer, with an accuracy rate ranging from 70% to 100%.
According to experts, the cure rate for late-stage cancer is very low; however, if detected early, the cure rate can be quite high. Therefore, scientists are constantly seeking methods to diagnose this disease in its early stages. To date, scientists worldwide have developed tests that can diagnose 1 to 3 types of early-stage cancer. But South Korea is the first country to develop a test that can detect 12 types of cancer.
This new technique from South Korea has applied for patents in both the country and internationally.
Tuyết Nhung
